Convatec Group plc

Headquarters: Reading, United Kingdom

Founded: 1978

Employees: 10,000

CEO: Mr. Karim Bitar

LSE: CTEC +2.09%

Market Cap

£5.02 Billion

GBP as of Jan. 1, 2024

US$6.39 Billion

Market Cap History

Convatec Group plc market capitalization over time

Evolution of Convatec Group plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Convatec Group plc

Detailed Description

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urological catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

Top 1-year algo backtest: +181.22%

$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Convatec Group plc has the following listings and related stock indices.

Stock: LSE: CTEC wb_incandescent

Stock: OTC: CNVVF wb_incandescent

Stock: FSX: 2CV wb_incandescent

Stock: FSX: 2CVU wb_incandescent

Product & Services

Wound and skin care, ostomy care, continence and critical care, infusion devices

Key People

Sir Christopher Gent​ (chairman) Karim Bitar (CEO)


Revenue: US$2,038.3 million (2021)

Operating income: US$203.6 million (2021)

Net income: US$117.6 million (2021)



3 Forbury Place

23 Forbury Road

Reading, RG1 3JH

United Kingdom

Phone: 44 11 8952 8100